102 Results for "

T2DM

" in MedChemExpress (MCE) Product Catalog:
Products (102)

102 Results for "T2DM" in MCE Product Catalog:

31
31 Publications Verification
Referencia número: HY-13687
No. CAS: 873225-46-8
Pureza:  99.88%
IKK 16 is an orally active IKK inhibitor. IKK 16 shows IC50s of 40 nM, 70 nM, 200 nM, and 50 nM for IKK2, IKK complex, IKK1, and LRRK 2, respectively. IKK 16 is also a pan-PKD inhibitor, inhibiting PKD1, PKD2, and PKD3 with IC50s of 153.9, 115, and 99.7 nM, respectively. IKK 16 is also an ABCB1 inhibitor, interfering with the binding of ABCB1 to its substrates. IKK 16 protects against LPS (HY-D1056)-induced multiple organ dysfunction by reducing the acute inflammatory response induced by endotoxin exposure. IKK 16 can restore renal function and alleviate fibrosis in acute kidney injury. IKK 16 attenuates cardiac dysfunction associated with polymicrobial sepsis in mice with type 2 diabetes mellitus (T2DM) by inhibiting the NF-κB pathway [2] .
loading...
    loading...
31
31 Publications Verification
Referencia número: HY-13687A
No. CAS: 1186195-62-9
Pureza:  99.95%
IKK 16 hydrochloride is an orally active IKK inhibitor. IKK 16 hydrochloride shows IC50s of 40 nM, 70 nM, 200 nM, and 50 nM for IKK2, IKK complex, IKK1, and LRRK 2, respectively. IKK 16 hydrochloride is also a pan-PKD inhibitor, inhibiting PKD1, PKD2, and PKD3 with IC50s of 153.9, 115, and 99.7 nM, respectively. IKK 16 hydrochloride is also an ABCB1 inhibitor, interfering with the binding of ABCB1 to its substrates. IKK 16 hydrochloride protects against LPS (HY-D1056)-induced multiple organ dysfunction by reducing the acute inflammatory response induced by endotoxin exposure. IKK 16 hydrochloride can restore renal function and alleviate fibrosis in acute kidney injury. IKK 16 hydrochloride attenuates cardiac dysfunction associated with polymicrobial sepsis in mice with type 2 diabetes mellitus (T2DM) by inhibiting the NF-κB pathway [2] .
loading...
    loading...
7
7 Cited Publications
Referencia número: HY-12066
No. CAS: 1032823-75-8
Pureza:  99.21%
Target:  

GPR119

Áreas de investigación:  

Metabolic Disease Inflammation/Immunology

GSK-1292263 is an orally available GPR119 agonist with pEC50s of 6.9 and 6.7 for human and rat GPR119, respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-14806A
No. CAS: 906093-29-6
Pureza:  99.99%
Synonyms: MP-513 hydrobromide
Teneligliptin (MP-513) hydrobromide is an orally active and selective dipeptidyl peptidase 4 (DPP-4) inhibitor (IC50s: 0.37 and 0.29 nM for the human and rat DPP-4, respectively). Teneligliptin hydrobromide improves blood glucose levels and can be used in researches related to type 2 diabetes mellitus [2] .
loading...
    loading...
6
6 Cited Publications
Referencia número: HY-14806B
No. CAS: 1572583-29-9
Pureza:  99.00%
Synonyms: MP-513 hydrobromide hydrate
Teneligliptin (MP-513) hydrobromide hydrate is an orally active and selective dipeptidyl peptidase 4 (DPP-4) inhibitor (IC50s: 0.37 and 0.29 nM for the human and rat DPP-4, respectively). Teneligliptin hydrobromide hydrate improves blood glucose levels and can be used in researches related to type 2 diabetes mellitus [2] .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-125824
No. CAS: 2230198-02-2
Pureza:  99.85%
Synonyms: PF-06882961
Target:  

GCGR

Áreas de investigación:  

Metabolic Disease

Danuglipron (PF-06882961) is an orally active glucagon-like peptide-1 receptor (GLP-1R) agonist. Danuglipron has the potential for type 2 diabetes research [2].
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-15527
No. CAS: 226954-04-7
Pureza:  99.94%
Synonyms: AC-5216; XBD-173
Target:  

TSPO

Áreas de investigación:  

Neurological Disease Metabolic Disease

Emapunil (AC-5216), an orally active and selective TSPO (a mitochondrial benzodiazepine receptor) ligand, produces anti-anxiety and antidepressant-like effects in various animal models [2].
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-119222
No. CAS: 862892-90-8
Pureza:  99.11%
Target:  

GPR109A

Áreas de investigación:  

Metabolic Disease

GSK256073 is a potent, selective and orally active GPR109A agonist and a long-lasting and non-flushing HCA2 full agonist with a pEC50 of 7.5 (human HCA2). GSK256073 acutely improves glucose homeostasis via inhibition of lipolysis and has the potential for the study of type 2 diabetes mellitus (T2DM)and dyslipidemia [2]. GPR109A: G-protein coupled receptor 109A; HCA2: hydroxy-carboxylic acid receptor 2
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-N1419
No. CAS: 53452-16-7
Vaccarin is an orally active flavonoid glycoside with multiple biological functions. Vaccarin promotes neovascularization by activating AKT and ERK. Vaccarin activates the AMPK signaling pathway to improve insulin resistance and steatosis. Vaccarin is a MAPK, NF-κB, and NFAT inhibitor, effectively blocking RANKL-induced osteoclastogenesis [2] .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-153800
No. CAS: 2712480-46-9
Pureza:  99.97%
Synonyms: (S)-MRI-1891; INV-202
Áreas de investigación:  

Metabolic Disease

Monlunabant ((S)-MRI-1891) is an orally active antagonist for cannabinoid receptor 1 (CB1), binds to hCB1 and hCB2 with Ki of 0.3 nM and 613 nM .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-19947
No. CAS: 1393124-08-7
Synonyms: Glucagon receptor antagonists-4
Target:  

GCGR

Áreas de investigación:  

Metabolic Disease

PF-06291874 is a highly potent, non-peptide and orally active glucagon receptor antagonist. PF-06291874 is under the study for type 2 diabetes mellitus (T2DM) [2].
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-112668A
No. CAS: 1174122-54-3
Pureza:  98.51%
Synonyms: SP2086
Target:  

Dipeptidyl Peptidase

Áreas de investigación:  

Metabolic Disease

Retagliptin (SP2086) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin can be used for type 2 diabetes mellitus (T2DM) research .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-15408
No. CAS: 865759-25-7
Pureza:  99.54%
Synonyms: SYR-472
Target:  

Dipeptidyl Peptidase

Áreas de investigación:  

Metabolic Disease

Trelagliptin (SYR-472) is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-112668
No. CAS: 1256756-88-3
Pureza:  99.71%
Synonyms: SP2086 phosphate
Target:  

Dipeptidyl Peptidase

Áreas de investigación:  

Metabolic Disease

Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-15408A
No. CAS: 1029877-94-8
Pureza:  99.96%
Synonyms: SYR-472 succinate
Target:  

Dipeptidyl Peptidase

Áreas de investigación:  

Metabolic Disease

Trelagliptin (SYR-472) succinate is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-B1021
No. CAS: 1617-90-9
Vincamine is a monoterpenoid indole alkaloid extracted from the Madagascar periwinkle. Vincamine is a peripheral vasodilator and exerts a selective vasoregulator action on the brain microcapilar circulation . Vincamine is a GPR40 agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS). Vincamine improves glucose homeostasis in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research [2].
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-19835
No. CAS: 1423018-12-5
Áreas de investigación:  

Metabolic Disease

LY2922470 is a selective and orally active agonist for the G protein-coupled receptor 40 (GPR40). LY2922470 activates GPR40-mediated β-arrestin recruitment with EC50s of 7 nM (human GPR40), 1 nM (mouse GPR40) and 3 nM (rat GPR40). LY2922470 can be used for research of type 2 diabetes mellitus (T2DM) .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-10449A
No. CAS: 1152425-66-5
Pureza:  99.20%
Synonyms: TS 071 hydrate
Target:  

SGLT

Áreas de investigación:  

Metabolic Disease

Luseogliflozin (TS 071) hydrate is a selective potent and orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor with an IC50 of 2.26 nM. Luseogliflozin hydrate can be used for the research of type 2 diabetes mellitus (T2DM) [2].
loading...
    loading...
Referencia número: HY-P3366
No. CAS: 2459531-73-6
Synonyms: XW003
Target:  

GCGR

Áreas de investigación:  

Metabolic Disease

Ecnoglutide (XW003) is a long-acting, cAMP-biased glucagon-like peptide 1 (GLP-1) receptor agonist. Ecnoglutide can be used for research of T2DM and obesity [2].
loading...
    loading...
Referencia número: HY-153865
No. CAS: 2401892-75-7
Pureza:  99.68%
Synonyms: PF-07081532
Target:  

GLP Receptor

Áreas de investigación:  

Metabolic Disease

Lotiglipron (PF-07081532) is an orally active GLP-1R agonist. Lotiglipron reduces glucose and body weight, and can be used for research of Type 2 diabetes mellitus (T2DM) .
loading...
    loading...